Altimmune ^Company

Altimmune focused on the development of products to stimulate robust and durable immune responses for the prevention. Design and synthesis of the single-dose vaccine have been completed, while animal testing will follow. The coronavirus vaccine is being developed based on a vaccine technology platform that is similar to NasoVAX, an influenza vaccine developed by Altimmune.